Alcohol consumption is a major cause of chronic liver disease. The disease, which has devastating consequences, progresses through stages of hepatitis (inflammation), fibrosis (scarring) and cirrhosis (severe scarring). Advanced ...
Jul 25, 2023
0
0
Staying healthy and connected was difficult for everyone during the COVID-19 pandemic, but especially so for homebound older patients and their caregivers. Fortunately, a program developed by the geriatrics and supportive ...
Jul 24, 2023
0
1
The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, ...
May 23, 2023
0
2
Intensive blood pressure treatment significantly reduces the risk of adverse cerebrovascular events such as stroke. New research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) shows ...
Apr 24, 2023
0
4
In a new study, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) link obesity with 21 Alzheimer's disease-related genes, providing a potential mechanistic explanation for ...
Feb 22, 2023
0
29
One-third of 986 patients achieved long-term self-care of their type 2 diabetes after building trusting relationships with community health workers (promotores in Spanish) over 12 weeks, according to a newly published study ...
Sep 26, 2022
0
36
Kidney cancer is not always confined to the kidney. In advanced cases, this cancer invades the body's biggest vein, the inferior vena cava (IVC), which carries blood out of the kidneys back to the heart. Via the IVC, cancer ...
Aug 19, 2022
0
18
Telehealth consultations with a pediatric infectious disease specialist at The University of Texas Health Science Center at San Antonio reduced the number of newborns receiving antibiotics by 32% in eight geographically distant ...
Jun 30, 2022
0
20
How much is an "acceptable dose" of a pollutant? Are existing studies to measure safety adequate? A systematic literature review by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) suggests ...
Jun 28, 2022
0
9
Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director ...
Jun 7, 2022
0
3
